Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
205.05
-3.40 (-1.63%)
Mar 5, 2026, 10:59 AM EST - Market open
Quest Diagnostics Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Quest Diagnostics stock have an average target of 208.62, with a low estimate of 178 and a high estimate of 235. The average target predicts an increase of 1.74% from the current stock price of 205.05.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Quest Diagnostics stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 9 | 9 | 9 | 9 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $210 → $235 | Buy | Maintains | $210 → $235 | +14.61% | Feb 12, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $205 → $220 | Hold | Maintains | $205 → $220 | +7.29% | Feb 11, 2026 |
| UBS | UBS | Hold Maintains $190 → $210 | Hold | Maintains | $190 → $210 | +2.41% | Feb 11, 2026 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $190 → $220 | Hold | Maintains | $190 → $220 | +7.29% | Feb 11, 2026 |
| Barclays | Barclays | Buy Maintains $210 → $225 | Buy | Maintains | $210 → $225 | +9.73% | Feb 11, 2026 |
Financial Forecast
Revenue This Year
11.87B
from 11.04B
Increased by 7.55%
Revenue Next Year
12.31B
from 11.87B
Increased by 3.75%
EPS This Year
10.74
from 8.75
Increased by 22.75%
EPS Next Year
11.55
from 10.74
Increased by 7.53%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 12.4B | 13.1B | ||
| Avg | 11.9B | 12.3B | ||
| Low | 11.3B | 11.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 12.4% | 10.2% | ||
| Avg | 7.5% | 3.7% | ||
| Low | 2.6% | -4.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 11.41 | 12.43 | ||
| Avg | 10.74 | 11.55 | ||
| Low | 10.29 | 10.87 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 30.4% | 15.8% | ||
| Avg | 22.7% | 7.5% | ||
| Low | 17.6% | 1.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.